I have come to agree with that last statement you made Seanl as I stated in another post. Big pharma, or big market players will not allow a stock now worth $29M US to accelerate to $2B without a buyout. I hope I'm wrong (I guess), but there is a decent chance of that happening before any pre-efficacy announcement. Why partner when you can just swoop in and buy the farm at this price?